ODACPhotoprotectionSkin Cancer

Controversies in Photoprotection

By June 1, 2020April 12th, 2023No Comments

Dermatology News

Video Pearls

Adam Friedman, MD, FAAD is Professor and Interim Chair of Dermatology and serves as Residency Program Director, Director of Translational Research, and Director of the Supportive OncodermatologyProgram in the Department of Dermatology at The George Washington University School of Medicine & Health Sciences. Dr. Friedman completed his undergraduate training at the University of Pennsylvania and graduated with Distinction in Dermatologic Research at the Albert Einstein College of Medicine in New York.

Learn More

Controversies in Photoprotection

featuring Dr. Adam Friedman

Journal of Drugs in Dermatology partners Next Steps in Derm and ODAC Dermatology Aesthetic and Surgical Conference interviewed Dr. Adam Friedman, Professor, Interim Chair of Dermatology, and Residency Program Director at George Washington University, on some of the common misconceptions and controversies surrounding photoprotection.

Debunking Misconceptions on Photoprotection

While ample evidence has shown that sunscreen not only reduces the incidences of melanoma, it also helps prevent  accelerated skin aging, many misconceptions about sunscreen are preventing patients from using what we have available to them.

Watch as Dr. Friedman debunks some of the current myths surrounding photoprotection and provides guidance on what we should really pay attention to.

Explore Photoprotection Articles

ODAC Orlando Dermatology, Aesthetic & Surgical Conference

ODAC Dermatology, Aesthetic and Surgical Conference (ODAC) is a distinguished ACCME accredited dermatology conference designed to meet the needs of medical and aesthetic dermatology providers in the 21st century. Founded in 2003 by dermatology pioneer, Dr. Perry Robins, the ODAC Dermatology Conference provides nearly 700 dermatologists, residents, nurse practitioners and physician assistants with important annual updates and fresh practical pearls in the field of medical, cosmetic and surgical dermatology in a highly interactive format.

Reasons to Attend ODAC 2021

  • Discuss the next generation of diagnostic approaches and evidence-based dermatology treatments
  • Observe cutting-edge procedures and techniques with live demonstrations of novel products and emerging technologies
  • Review clinical trial results and discuss case-studies in both large and small group settings
  • Cultivate relationships with colleagues and leaders actively shaping the future of dermatology
  • Earn CME –  up to 31 AMA PRA Category 1 Credits™
Register for ODAC 2021 Now

You May Also Like

Journal of Drugs in Dermatology JDD Article about Antiviral Treatment of Herpes Simplex Virus Decreases the Risk of Alzheimer’s Disease and Dementia

Antiviral Treatment of Herpes Simplex Virus Decreases the Risk of Alzheimer’s Disease and Dementia

| Featured Articles, Latest News, Medical Derm | No Comments
A large real world TriNetX analysis reports an association between antiviral treatment for oral or mucocutaneous HSV and lower rates of Alzheimer disease and dementia If you’ve missed this must-read…
Journal of Drugs in Dermatology JDD Article about From the Vault: Innate Error Immunities of the Th17 Immune Pathway Associated With Chronic Mucocutaneous Candidiasis: A Systematic Review

From the Vault: Innate Error Immunities of the Th17 Immune Pathway Associated With Chronic Mucocutaneous Candidiasis: A Systematic Review

| Featured Articles, Latest News, Medical Derm | No Comments
Have you read this JDD review on Th17 pathway defects and chronic mucocutaneous candidiasis? We pulled this one from the JDD vault - a must read article that dates back…
Journal of Drugs in Dermatology JDD Article about From Bald to Bold: Reversal of Alopecia Totalis in an Adolescent Using Dupilumab Monotherapy

From Bald to Bold: Reversal of Alopecia Totalis in an Adolescent Using Dupilumab Monotherapy

| Alopecia, Case Reports, Featured Articles, Hair, Latest News, Pediatrics | No Comments
A pediatric case links dupilumab therapy for atopic dermatitis with sustained hair regrowth in extensive alopecia areata Dive into this recent JDD Case Study A single-patient case report describes a…

Leave a Reply